Apollo Hospitals Enterprise · NSE: APOLLOHOSP · BSE: 508869

Q4 FY25 results · Jan–Mar 2025

Apollo Hospitals Enterprise reported revenue from operations of ₹5,592.20 crore (up 13.1% from Q4 FY24) and net profit of ₹414.50 crore (up 60.4% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY25	Q4 FY24	YoY	Q3 FY25	QoQ
Revenue from operations	5,592.20	4,943.90	+13.1%	5,526.90	+1.2%
Other income	61.10	28.10	+117.4%	63.80	−4.2%
Total income	5,653.30	4,972.00	+13.7%	5,590.70	+1.1%
Profit before share of associates & JVs and tax	505.00	359.60	+40.4%	530.90	−4.9%
Share of profit/(loss) of associates & JVs	10.50	8.60		5.30
Net profit for the period	414.50	258.40	+60.4%	379.40	+9.3%
Attributable to shareholders of the company	389.60	253.80	+53.5%	372.30	+4.6%
EPS, basic (₹)	27.10	17.65	not comparable	25.89	not comparable
Net margin (%)	7.4	5.2		6.9

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY25	Q4 FY24	YoY	Q3 FY25	QoQ
Revenue from operations	2,075.30	1,894.60	+9.5%	2,054.80	+1.0%
Other income	91.60	46.00	+99.1%	107.90	−15.1%
Total income	2,166.90	1,940.60	+11.7%	2,162.70	+0.2%
Profit before tax	420.00	312.40	+34.4%	449.30	−6.5%
Net profit for the period	333.40	238.80	+39.6%	341.60	−2.4%
EPS, basic (₹)	23.18	16.61	not comparable	23.76	not comparable
Net margin (%)	16.1	12.6		16.6

Consolidated

Filed with BSE: 30 May 2025, 23:00 IST
Board meeting: 30 May 2025
Period: 01 Jan 2025 to 31 Mar 2025
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 30 May 2025, 23:00 IST
Board meeting: 30 May 2025
Period: 01 Jan 2025 to 31 Mar 2025
Review status: Audited
Source: XBRL filing on BSE